Prognostic value of soluble ST2 in adults with congenital heart disease.
Laurie W GeenenVivan J M BaggenAnnemien E van den BoschJannet A EindhovenJudith A A E CuypersMaarten WitsenburgEric BoersmaJolien W Roos-HesselinkPublished in: Heart (British Cardiac Society) (2019)
sST2 is a promising novel biomarker in patients with ACHD, specifically in complex ACHD and women. Future research is warranted to elucidate sex-specific and diagnosis-specific differences.